Limited-Time Offer: Get 40% OFF on selected medicine

Anti-Counterfeit & Supply Chain Integrity Policy

Pharmaceutical Wholesales & Global Distribution

Our Absolute Position: Zero Counterfeit Standard™

Apple Globalcare operates under a strict Zero Counterfeit Standard™. We categorically prohibit the purchase, sale, distribution, promotion, or facilitation of any falsified, diverted, tampered, stolen, misbranded, or unauthorized pharmaceutical products.

Patient safety, regulatory compliance, and supply chain integrity take precedence over all commercial considerations. If authenticity cannot be verified through documented and regulatory evidence, the product does not move.

What We Define as Counterfeit or Unauthorized: No Compromise on Authenticity

We define counterfeit or unauthorized products to include:

  • Falsified or fake medicines
  • Diverted or stolen goods
  • Tampered or altered packaging
  • Products sourced from unauthorized channels
  • Deceptive copies or look-alike products
  • Materials infringing intellectual property rights

This includes items marketed as “replica,” “dupe,” “100% authentic copy,” “unauthorized reseller,” “fake,” or “knockoff.” Such products are strictly prohibited within our supply chain.

Project Zero – Our Anti-Counterfeit Program: Structured Prevention & Control

Project Zero is our structured anti-counterfeit and product integrity framework. It includes:

  • Authenticity verification procedures
  • Supplier qualification and due diligence
  • Documentation review and validation
  • Batch-level traceability controls
  • Risk monitoring and escalation protocols
  • Cooperation with rights holders and regulators

Project Zero ensures preventive action rather than reactive response.

Sourcing Discipline: Authorized Partners Only

We procure exclusively from licensed, authorized, and verifiable partners. Every supplier must demonstrate:

  • Valid regulatory authorization
  • Traceable documentation
  • Transparent product origin
  • Compliance with GDP and applicable regulations

Unverified or high-risk sources are immediately excluded from consideration.

Traceability & Documentation: Proof Before Distribution

We require clear documentation at every stage of the supply chain, including:

  • Batch identification and traceability
  • Supplier validation records
  • Product origin evidence
  • Controlled storage and transport history
  • Recall readiness documentation

Every shipment must be auditable, traceable, and defensible.

Intellectual Property Respect: Full Legal & IP Compliance

Apple Globalcare respects patents, trademarks, copyrights, data exclusivities, and regulatory protections. We do not trade in products that infringe intellectual property rights.

Where concerns arise, we cooperate fully with lawful enforcement authorities and rights holders.

Technology & Monitoring: Proactive Risk Detection

We deploy appropriate technological and monitoring tools to strengthen supply chain integrity, including:

  • Digital verification mechanisms
  • Screening and transaction review
  • Anomaly detection systems
  • Market intelligence monitoring

These tools enhance transparency and early risk identification.

Zero Tolerance Enforcement: Immediate Action on Suspicion

Where product authenticity concerns arise, Apple Globalcare may:

  • Suspend or block transactions
  • Seek additional verification
  • Notify stakeholders
  • Terminate supplier relationships
  • Cooperate with regulatory or enforcement authorities

Non-compliance with this policy results in immediate and decisive action.

Protection of Patients & Partners: Safety Above All

Counterfeit prevention is a patient protection obligation. Our commitment safeguards:

  • Patients and caregivers
  • Healthcare institutions
  • Manufacturers and innovators
  • Regulatory authorities

We recognize that product integrity directly impacts health outcomes and public trust.

Reporting Suspicions: Speak Up with Confidence

Suspected counterfeit, diversion, tampering, or unauthorized activity can be reported confidentially to:

📧 compliance@appleglc.com

All reports are reviewed promptly and handled with appropriate confidentiality and non-retaliation protections.

Continuous Strengthening: Always Improving Controls

We continually enhance our supplier evaluation standards, risk assessments, monitoring tools, and internal training programs.

Supply chain integrity is a dynamic responsibility requiring continuous vigilance and improvement.

Public Commitment: Transparency in Standards

This Anti-Counterfeit & Supply Chain Integrity Policy is publicly available at:

🌐 www.appleglc.com

Transparency reinforces accountability.

Our Principle

If Authenticity Cannot Be Proven, the Product Does Not Move.

This principle governs every sourcing and distribution decision at Apple Globalcare. No exceptions. No compromise.

Policy Control & Governance

Policy Owner: Compliance & Regulatory Affairs Department
Approval Authority: Board of Directors
Review Cycle: Annual Review or Upon Regulatory Change
Effective Date: [01.01.2026]
Version: 1.0